Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 234,107 | 312,332 | 254,844 | 861,312 | 356,409 |
| Marketable Securities | 234,830 | 682,401 | 1,280,833 | 1,553,409 | 360,330 |
| Receivables | N/A | N/A | N/A | N/A | 773,079 |
| TOTAL | $514,080 | $1,042,458 | $1,588,226 | $2,519,077 | $1,562,821 |
| Non-Current Assets | |||||
| PPE Net | 55,620 | 63,183 | 96,018 | 105,609 | 42,834 |
| Investments And Advances | 314,575 | 190,015 | 105,275 | 23,927 | 201,388 |
| Intangibles | 24,787 | 25,057 | 39,502 | 49,692 | 50,224 |
| Other Non-Current Assets | 93,761 | 78,100 | 90,039 | 103,783 | 97,001 |
| TOTAL | $488,743 | $356,355 | $330,834 | $283,011 | $391,447 |
| Total Assets | $1,002,823 | $1,398,813 | $1,919,060 | $2,802,088 | $1,954,268 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,803 | 5,081 | 6,334 | 6,422 | 6,521 |
| Accrued Expenses | 83,012 | 98,521 | 104,220 | 489,090 | 236,512 |
| Other current liabilities | N/A | 16,060 | N/A | N/A | N/A |
| TOTAL | $92,815 | $119,662 | $175,407 | $511,029 | $341,242 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 64,853 | 15,517 | 98,209 |
| Other Non-Current Liabilities | 144,732 | 128,766 | 153,473 | 159,889 | 158,923 |
| TOTAL | $144,732 | $128,766 | $153,417 | $213,096 | $181,177 |
| Total Liabilities | $237,547 | $248,428 | $328,824 | $724,125 | $522,419 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 139,517 | 137,143 | 135,032 | 133,531 | 132,304 |
| Common Shares | 14 | 14 | 13 | 13 | 13 |
| Retained earnings | -1,197,771 | -759,784 | -237,824 | 377,237 | -138,600 |
| Other shareholders' equity | -2,057 | -1,717 | -815 | -9,122 | -1,099 |
| TOTAL | $765,276 | $1,150,385 | $1,590,236 | $2,077,963 | $1,431,849 |
| Total Liabilities And Equity | $1,002,823 | $1,398,813 | $1,919,060 | $2,802,088 | $1,954,268 |